OMNIAB, INC. Gain (Loss) on Investments
OMNIAB, INC. (OABI) reported Gain (Loss) on Investments of $1.09 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.
Discontinued › Income Statement › Other Income
us-gaap:GainLossOnInvestments · last filed 2022-11-10
- OMNIAB, INC. gain (loss) on investments for the quarter ending 2022-09-30 was $1.09M.
- OMNIAB, INC. gain (loss) on investments for the quarter ending 2022-06-30 was $297.05K.
| Period end | Gain (Loss) on Investments 3 month | Gain (Loss) on Investments 6 month | Gain (Loss) on Investments 9 month |
|---|---|---|---|
| 2022-09-30 | $1.09M 10-Q · filed 2022-11-10 | $1.39M derived: sum of 2 quarters · filed 2022-11-10 | $1.44M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $297.05K 10-Q · filed 2022-08-12 | $348.33K 10-Q · filed 2022-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |